Immunohistochemical detection of angiotensin receptors AT1 and AT2 in adrenal tumors

Folia Histochemica et Cytobiologica

Volumn 46, Issue 1, 2008, Pages 51-55

  Pawlikowski, Marek ^a   Winczyk, Katarzyna ^a   Śledź, Beata ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Adrenal gland; Adrenal tumors; Angotensin receptors; AT1; AT2; Immunohistochemistry

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; HYDROCORTISONE; PARAFFIN; RECEPTOR ANTIBODY;

ADRENAL CANCER; ADRENAL CORTEX ADENOMA; ADRENAL TUMOR; ARTICLE; CARCINOGENESIS; CELL MEMBRANE; CELL NUCLEUS; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING SYNDROME; CYTOPLASM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERSTITIUM; PHEOCHROMOCYTOMA; TUMOR ASSOCIATED LEUKOCYTE; HYPERPLASIA; METABOLISM; PATHOLOGY; SECRETION;

ADRENAL GLAND NEOPLASMS; ADRENOCORTICAL ADENOMA; ALDOSTERONE; HUMANS; HYDROCORTISONE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2;

EID: 41649094863     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-008-0006-7     Document Type: Article

References (19)

1. McEwen PE, Lindop GB, Kenyon CJ. Control of cell proliferation in the rat adrenal gland in vivo by the renin-angiotensin system. Am J Physiol. 1996;271:E192-E198.
2. Tanabe A, Naruse M, Arai K, Naruse K, Yoshimito T, Seki T, Imaki T, Kobayashi M, Miyazaki H, Demura H. Angiotensin II stimulates both aldosterone secretion and DNA synthesis via type 1 but not type 2 receptors in bovine adrenocortical cells. J Endcrinol Invest. 1998;21:668-672.
3. Pawlikowski M, Gruszka A, Mucha S, Melen-Mucha G. Angiotensins II and IV stimulate the rat adrenocortical cell-proliferation acting via different receptors. Endocrine Regul. 2001;35:139-142.
4. Fallo F, Postorello M, Pedini F, D'Agostino D, Mantero F, Boscaro M. In vitro evidence for local generation of renin and angiotensin II/III immunoreactivity by the human adrenal gland. Acta Endocrionol. 1991;125:319-330.
5. Oda N, Takeda Y, Zhu A, Usukara M, Yoneda T, Takata H, Mabuchi H. Pathophysiological role s of the adrenal renin-angiotensin system in patients with primary aldosteronism. Hypertens Res. 2006;29:9-14.
6. Lu XY, KL Cove, Zhang W, Speth RC. Pharmacological characterization of angiotensin II AT2 receptor subtypee heterogenity in the rat adrenal cortex and medulla. Endocrine. 1995; 3:255-261.
7. Naruse M, Tanabe A, Sugaya T, Naruse K, Yoshimito T, Seki T, Imaki T, Demura R, Murakami K, Demura H. Differential role of angiotensin receptor subtypes in adrenocortical function in mice. Life Sci. 1998;63:1593-1598.
8. Tanabe A, Naruse M, Arai K, Naruse K, Yoshimito T, Seki T, Imaki T, Miyazaki H, Zeng ZP, Demura R, Demura H. Gene expression and roles of angiotensin II type 1 and type 2 receptors in human adrenals. Horm Metab Res. 1998;30:490-495.
9. Cook MD, Philips MI, Cook VI, kimura B, Wilcox CSA. Angiotensin II receptor subtypes on adrenal adenoma in primary hyperaldosteronism. J Am Soc Nephrol. 1993;4:111-116.
10. Sarzani R, Opocher G, Dessi-Fulgheri P, Paci V, Cola G, Rocco S, Vianello B, Mantero F, Reppelli A. Expression of type 1 angiotensin II receptors in human aldosteronomas. Endocr Res. 1995;21:189-195.
11. Opocher G, Rocco S, Cimolato M, Vianello B, Arnaldi G, Mantero F. Angiotensin II receptors in cotrical and medullary adrenal tumors. J Clin Endocrinol Metab. 1997;82:865-869.
12. Kitamura Y, Sasamura H, Maruyama T, Nakaya H, Amemiya T, Hayashi M, Satura T. Adrenal angiotensin type 1 and type 2 receptors in Cushing's and Conn's syndrome. Mol Cell Endocrinol. 1998;144:37-45.
13. Chen YM, Wu KD, Hu-Tsai MI, Chu JS, Lai MK, Hsich BS. Differential expression of type 1 angiotensin receptor mRNA and aldosterone responsiveness to angiotensin in aldosterone-producing adenoma. Mol Cell Endocrinol. 1999;25,152:47-55.
14. Schubert B, Fassnacht M, Beuschlein F, Zenkert S, Allolio B, Reincke M. Angiotensin II type1 receptor and ACTH receptor expression in human adrenocortical neoplasms. Clinical Endocrinology. 2001;54:627-632.
15. Tang SS, Rogg H, Schumacher R, Dzau VJ. Characterization of nuclear angiotensin II-binding sites in rat liver and comparison with plasma membrane receptors. Endocrinology. 1992;131:374-380.
16. Cook JL, Zhang Z, Re RN. In vitro evidence for an intracellular site of angiotensin action. Circulation Res. 2001;89: 1138-1146.
17. Wolf G, Harendza S, Schroeder R, Wenzel U, Zahner G, Butzmann U, Freeman RS, Stahl RA. Angiotensin II's antiproliferative effects mediated through AT2 receptors depend on down-regulation of SM-20. J Lab Invest. 2002;82: 1305-1317.
18. Pawlikowski M. Immunohistochemical detection of angiotensin receptors AT1 and AT2 in normal rat pituitary gland, estregen-induced rat pituitary tumor and human pituitary adenomas. Folia Histochem Cytobiol. 2006;44:175-177.
19. Zhang N, Lassila M, Cooper ME, Cao Z. Retinal expression of vascular endothelial growth factor is mediated by angiotensin type 1 and type 2 receptors. Hypertension. 2004; 43:276-281.